{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:41:16Z","timestamp":1792784476786,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"DMID-NIAID","award":["U01 A0I77887"],"award-info":[{"award-number":["U01 A0I77887"]}]},{"name":"DMID-NIAID","award":["R01 27530"],"award-info":[{"award-number":["R01 27530"]}]},{"DOI":"10.13039\/100001209","name":"Knights Templar Eye Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001209","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001818","name":"The Research to Prevent Blindness Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.03.092","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T10:02:13Z","timestamp":1397383333000},"page":"3243-3248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice"],"prefix":"10.1016","volume":"32","author":[{"given":"Kamal","family":"El Bissati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debleena","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Cobb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitender P.","family":"Dubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Burkhard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Lanar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2014.03.092_bib0005","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1590\/S0074-02762009000200029","article-title":"Why prevent, diagnose and treat congenital toxoplasmosis?","volume":"104","author":"McLeod","year":"2009","journal-title":"Mem Inst Oswaldo Cruz"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0010","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/clinids\/18.1.38","article-title":"Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: the Chicago Collaborative Treatment Trial","volume":"18","author":"McAuley","year":"1994","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0015","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/1475-2875-12-357","article-title":"Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine","volume":"12","author":"McCoy","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0020","doi-asserted-by":"crossref","first-page":"7268","DOI":"10.4049\/jimmunol.0901957","article-title":"A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria","volume":"183","author":"Kaba","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0025","doi-asserted-by":"crossref","first-page":"e48304","DOI":"10.1371\/journal.pone.0048304","article-title":"Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine","volume":"7","author":"Kaba","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0030","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ymeth.2013.03.025","article-title":"Expression, purification and refolding of a self-assembling protein nanoparticle (SAPN) malaria vaccine","volume":"60","author":"Guo","year":"2013","journal-title":"Methods"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0035","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jsps.2011.06.003","article-title":"Vaccine adjuvants \u2013 current status and prospects on controlled release adjuvancity","volume":"19","author":"Sivakumar","year":"2011","journal-title":"Saudi Pharm J"},{"issue":"Pt 3","key":"10.1016\/j.vaccine.2014.03.092_bib0040","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1017\/S0031182099004692","article-title":"In vivo expression and distribution of dense granule protein 7 (GRA7) in the exoenteric (tachyzoite, bradyzoite) and enteric (coccidian) forms of Toxoplasma gondii","volume":"119","author":"Ferguson","year":"1999","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0045","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1086\/374647","article-title":"Serotyping of Toxoplasma gondii infections in humans using synthetic peptides","volume":"187","author":"Kong","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humimm.2011.10.006","article-title":"Toxoplasma gondii HLA-B*0702-restricted GRA7(20-28) peptide with adjuvants and a universal helper T cell epitope elicits CD8(+) T cells producing interferon-gamma and reduces parasite burden in HLA-B*0702 mice","volume":"73","author":"Cong","year":"2011","journal-title":"Hum Immunol"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0055","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jconrel.2013.07.030","article-title":"Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis","volume":"172","author":"Orr","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0060","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1016\/j.vaccine.2012.06.081","article-title":"Enhancement of protective immune responses induced by Toxoplasma gondii dense granule antigen 7 (GRA7) against toxoplasmosis in mice using a prime-boost vaccination strategy","volume":"30","author":"Min","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0065","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-3024.2007.00961.x","article-title":"GRA7 provides protective immunity in cocktail DNA vaccines against Toxoplasma gondii","volume":"29","author":"Jongert","year":"2007","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0070","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S1074-7613(94)80017-0","article-title":"Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides","volume":"1","author":"Alexander","year":"1994","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0075","doi-asserted-by":"crossref","first-page":"13419","DOI":"10.1073\/pnas.95.23.13419","article-title":"An autonomous folding unit mediates the assembly of two-stranded coiled coils","volume":"95","author":"Kammerer","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0080","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.nano.2006.04.007","article-title":"Structure-based design of peptides that self-assemble into regular polyhedral nanoparticles","volume":"2","author":"Raman","year":"2006","journal-title":"Nanomedicine"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0085","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1126\/science.274.5288.761","article-title":"The crystal structure of a five-stranded coiled coil in COMP: a prototype ion channel?","volume":"274","author":"Malashkevich","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0090","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.vaccine.2010.11.015","article-title":"Towards an immunosense vaccine to prevent toxoplasmosis: protective Toxoplasma gondii epitopes restricted by HLA-A*0201","volume":"29","author":"Cong","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0095","doi-asserted-by":"crossref","first-page":"16156","DOI":"10.1073\/pnas.0405319101","article-title":"Atomic structure of a tryptophan-zipper pentamer","volume":"101","author":"Liu","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0100","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1016\/j.biomaterials.2007.04.023","article-title":"Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives","volume":"28","author":"Akagi","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1021\/mp060096p","article-title":"Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus","volume":"4","author":"Mottram","year":"2007","journal-title":"Mol Pharm"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0110","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.it.2006.10.005","article-title":"Targeting dendritic cells with biomaterials: developing the next generation of vaccines","volume":"27","author":"Reddy","year":"2006","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0115","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.vetpar.2010.11.047","article-title":"Evaluation of immune responses in sheep induced by DNA immunization with genes encoding GRA1, GRA4, GRA6 and GRA7 antigens of Toxoplasma gondii","volume":"177","author":"Hiszczynska-Sawicka","year":"2011","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0120","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.4049\/jimmunol.145.10.3438","article-title":"Class I MHC genes and CD8+T cells determine cyst number in Toxoplasma gondii infection","volume":"145","author":"Brown","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0125","doi-asserted-by":"crossref","first-page":"286","DOI":"10.4049\/jimmunol.146.1.286","article-title":"Synergistic role of CD4+ and CD8+T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine","volume":"146","author":"Gazzinelli","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0130","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.4049\/jimmunol.168.12.6189","article-title":"A decaepitope polypeptide primes for multiple CD8+ IFN-gamma and Th lymphocyte responses: evaluation of multiepitope polypeptides as a mode for vaccine delivery","volume":"168","author":"Alexander","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1745-7580-6-12","volume":"6","author":"Cong","year":"2010","journal-title":"Immunome Res"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0140","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1475-2875-12-136","article-title":"Mechanisms of protective immune responses induced by the Plasmodium falciparum circumsporozoite protein-based, self-assembling protein nanoparticle vaccine","volume":"12","author":"McCoy","year":"2013","journal-title":"Malar J"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0145","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1747-0285.2008.00746.x","article-title":"Peptide nanoparticles as novel immunogens: design and analysis of a prototypic severe acute respiratory syndrome vaccine","volume":"73","author":"Pimentel","year":"2009","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0150","first-page":"419","article-title":"Definitive identification of a gene that confers resistance against Toxoplasma cyst burden and encephalitis","volume":"85","author":"Brown","year":"1995","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0155","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-gamma: the major mediator of resistance against Toxoplasma gondii","volume":"240","author":"Suzuki","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0160","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.164.5.2629","article-title":"Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase","volume":"164","author":"Kang","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2014.03.092_bib0165","doi-asserted-by":"crossref","first-page":"e1003449","DOI":"10.1371\/journal.ppat.1003449","article-title":"Location of the CD8T cell epitope within the antigenic precursor determines immunogenicity and protection against the Toxoplasma gondii parasite","volume":"9","author":"Feliu","year":"2013","journal-title":"PLoS Pathog"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14004836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T22:54:55Z","timestamp":1689116095000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14004836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":33,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X14004836"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.092","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of a novel immunogenic nanoparticle platform for Toxoplasma peptide vaccine in HLA transgenic mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.092","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}